Pay in 4 interest-free payments of $6.49 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
The single-center, double-blind, randomized, placebo-controlled trial in healthy postmenopausal women will study the safety, pharmacokinetics and change in biomarkers related to activin and GDF biology following subcutaneous administration of HS135
In a randomized, double-blind, breast cancer prevention trial (NSABP P-1 trial), hot flashes (any severity, 80% vs 68%
doi: 10.1002/dmrr.v29.1 32 SchauerIESnell-BergeonJKBergmanBCMaahsDMKretowskiAEckelRHet al
References Fras, J
Pour toute demande d'utilisation (exemple d'un formateur Bio de la FFESSM...) contactez nous ici.
US$ 3497.50
Sold : Login>>
